Physician profile
Tamara Gallardo
NPI 1952996472
$656.16
in general payments reported to CMS, 2019-2025
19 companies · $75.59 in 2025
The $75.59 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $157 · 2023: $276 · 2024: $147 · 2025: $75.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $499.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $498.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $128.95 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Amgen INC. | $55.98 | 2022-2023 | Blincyto |
| Pfizer INC. | $53.07 | 2025 | |
| Genentech USA, INC. | $52.73 | 2022-2023 | Columvi, Polivy |
| Novartis Pharmaceuticals Corporation | $42.24 | 2022 | |
| Adc Therapeutics America, INC. | $40.22 | 2023-2024 | |
| Immunocore Limited | $38.24 | 2023 | Kimmtrak |
| Tersera Therapeutics LLC | $35.54 | 2023 | Zoladex |
| Alkermes, INC. | $24.59 | 2024 | Lybalvi |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $21.52 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.25 | 2023 | |
| Janssen Scientific Affairs, LLC | $19.66 | 2024 | Spravato |
| Abbvie INC. | $18.92 | 2024 | |
| Genmab U.S., INC. | $18.27 | 2023 | Epkinly |
| Eisai INC. | $18.27 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $18.05 | 2023 | Bavencio |
| Daiichi Sankyo INC. | $18.03 | 2022 | |
| Gilead Sciences, INC. | $16.20 | 2022 | |
| Glaxosmithkline, LLC. | $14.43 | 2023 | Jemperli, Zejula |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamara Gallardo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.